Welcome to LookChem.com Sign In|Join Free

CAS

  • or
6-Monodeoxy-6-monoamino-beta-cyclodextrine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

29390-67-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • China Largest Factory Manufacturer sales 6-Monodeoxy-6-monoamino-beta-cyclodextrine CAS 29390-67-8

    Cas No: 29390-67-8

  • USD $ 1.0-2.0 / Kilogram

  • 500 Kilogram

  • 20 Metric Ton/Month

  • Leader Biochemical Group
  • Contact Supplier
  • 29390-67-8 Structure
  • Basic information

    1. Product Name: 6-Monodeoxy-6-monoamino-beta-cyclodextrine
    2. Synonyms: 6-Monodeoxy-6-monoamino-beta-cyclodextrine;Mono-6-Amino-6-deoxy-beta-Cyclodextrin;6-AMino-6-deoxy -cyclodextrin;mono-6-amino-mono-6-deoxy-β-CD;Mono-(6-amino-6-deoxy)-β-cyclodextrin;Mono-(6-amino-6-deoxy)-2-cyclodextrin
    3. CAS NO:29390-67-8
    4. Molecular Formula: C42H71NO34
    5. Molecular Weight: 1133.99944
    6. EINECS: 1312995-182-4
    7. Product Categories: Cyclodextrins
    8. Mol File: 29390-67-8.mol
  • Chemical Properties

    1. Melting Point: 203 °C (decomp)
    2. Boiling Point: 1527.8±60.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: White to off-white/Solid powder or crystals
    5. Density: 1.608±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
    8. Solubility: Soluble in water, DMF, DMSO.Insoluble in acetone, methanol, chlo
    9. PKA: 12.57±0.70(Predicted)
    10. Stability: Hygroscopic
    11. CAS DataBase Reference: 6-Monodeoxy-6-monoamino-beta-cyclodextrine(CAS DataBase Reference)
    12. NIST Chemistry Reference: 6-Monodeoxy-6-monoamino-beta-cyclodextrine(29390-67-8)
    13. EPA Substance Registry System: 6-Monodeoxy-6-monoamino-beta-cyclodextrine(29390-67-8)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 29390-67-8(Hazardous Substances Data)

29390-67-8 Usage

Chemical Properties

suitable for coupling to carboxyl- or aldehyde-containing ligands

Uses

Different sources of media describe the Uses of 29390-67-8 differently. You can refer to the following data:
1. suitable for coupling to carboxyl- or aldehyde-containing ligands
2. 6-Monoamino-β-cyclodextrin is synthesized as fluorescent sensor of moleclular recognition.

Check Digit Verification of cas no

The CAS Registry Mumber 29390-67-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,3,9 and 0 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 29390-67:
(7*2)+(6*9)+(5*3)+(4*9)+(3*0)+(2*6)+(1*7)=138
138 % 10 = 8
So 29390-67-8 is a valid CAS Registry Number.

29390-67-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name mono-6-amino-mono-6-deoxy-β-CD

1.2 Other means of identification

Product number -
Other names 6-AMINO-6-DEOXY SS-CYCLODEXTRIN

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:29390-67-8 SDS

29390-67-8Synthetic route

mono(6-azido-6-deoxy)β-cyclodextrin
98169-85-8

mono(6-azido-6-deoxy)β-cyclodextrin

6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

Conditions
ConditionsYield
With triphenylphosphine In N,N-dimethyl-formamide for 1h; Ambient temperature;99%
Stage #1: mono(6-azido-6-deoxy)β-cyclodextrin With triphenylphosphine In N,N-dimethyl-formamide for 2h;
Stage #2: With water In N,N-dimethyl-formamide for 0.5h; Heating;
97%
Stage #1: mono(6-azido-6-deoxy)β-cyclodextrin With triphenylphosphine In N,N-dimethyl-formamide at 20℃;
Stage #2: With ammonium hydroxide In N,N-dimethyl-formamide at 20℃; for 0.166667h;
95%
mono-6-deoxy-6-(p-tolylsulphonyl)-β-cyclodextrin
67217-55-4

mono-6-deoxy-6-(p-tolylsulphonyl)-β-cyclodextrin

6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

Conditions
ConditionsYield
With ammonia In water at 20℃; for 168h;90%
With ammonium hydroxide In water at 50℃; for 72h;79%
With ammonium hydroxide In water at 85℃; for 0.5h; Microwave irradiation;60%
6-monodeoxy-6-monoamino-β-cyclodextrin hydrochloride

6-monodeoxy-6-monoamino-β-cyclodextrin hydrochloride

6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

Conditions
ConditionsYield
With ammonium hydroxide In water at 20℃;88%
mono-6-deoxy-6-(p-tolylsulphonyl)-β-cyclodextrin
67217-55-4

mono-6-deoxy-6-(p-tolylsulphonyl)-β-cyclodextrin

A

6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With ammonia In water at 60℃; for 5h; Product distribution / selectivity;A 70%
B 30%
mono(6-azido-6-deoxy)β-cyclodextrin
98169-85-8

mono(6-azido-6-deoxy)β-cyclodextrin

A

6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With ammonium hydroxide; triphenylphosphine 1) DMF; Yield given. Multistep reaction. Yields of byproduct given;
6-deoxy-6-(N-hydroxylamino)-β-cyclodextrin
138435-33-3

6-deoxy-6-(N-hydroxylamino)-β-cyclodextrin

6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In water under 1292.9 Torr; for 20h;
C62H97NO34

C62H97NO34

A

all-trans-Retinal
116-31-4

all-trans-Retinal

B

6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

Conditions
ConditionsYield
With water In various solvent(s) at 25℃; pH=4.0; Kinetics; Further Variations:; Reagents;
C42H71NO34*C22H21O6PS2(2-)*2Na(1+)

C42H71NO34*C22H21O6PS2(2-)*2Na(1+)

A

6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

B

bis(3-sulfonatophenyl)(4-tert-butylphenyl)phosphane disodium salt

bis(3-sulfonatophenyl)(4-tert-butylphenyl)phosphane disodium salt

Conditions
ConditionsYield
In water-d2 at 25℃; Equilibrium constant;
β‐cyclodextrin
7585-39-9

β‐cyclodextrin

6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

Conditions
ConditionsYield
Stage #1: β‐cyclodextrin With p-toluenesulfonyl chloride In pyridine
Stage #2: With sodium azide In N,N-dimethyl-formamide
Stage #3: With palladium on activated charcoal; hydrazine hydrate
1,1,2,2-tetrachloroethane
79-34-5

1,1,2,2-tetrachloroethane

6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

Conditions
ConditionsYield
With sodium azide; triphenylphosphine In [(2)H6]acetone; water
C60H84NO34P

C60H84NO34P

6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

Conditions
ConditionsYield
With ammonium hydroxide
6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

N-acetyl-DL-tryptophan
1218-34-4, 87-32-1

N-acetyl-DL-tryptophan

mono-6-(N-acetyltryptophanyl)amino-6-deoxy-β-cyclodextrin

mono-6-(N-acetyltryptophanyl)amino-6-deoxy-β-cyclodextrin

Conditions
ConditionsYield
With benzotriazol-1-ol; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide for 48h; Ambient temperature;91%
6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

bromoacetic acid
79-08-3

bromoacetic acid

mono-6-deoxy-6-bromoacetylamino-β-cyclodextrin
682357-43-3

mono-6-deoxy-6-bromoacetylamino-β-cyclodextrin

Conditions
ConditionsYield
Stage #1: bromoacetic acid With benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide for 3h;
Stage #2: 6(I)-amino-6(I)-deoxycyclomaltoheptaose In N,N-dimethyl-formamide for 2h; Further stages.;
91%
N-Fmoc L-Phe
35661-40-6

N-Fmoc L-Phe

6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

6--6-deoxycyclomaltoheptaose

6--6-deoxycyclomaltoheptaose

Conditions
ConditionsYield
With benzotriazol-1-ol; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide at 0℃; for 15h;90%
succinic acid anhydride
108-30-5

succinic acid anhydride

6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

mono-6'-deoxy-6'-amidosuccinyl-β-cyclomaltoheptaose
136790-52-8

mono-6'-deoxy-6'-amidosuccinyl-β-cyclomaltoheptaose

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 20℃; for 12h;90%
Stage #1: succinic acid anhydride; 6(I)-amino-6(I)-deoxycyclomaltoheptaose With triethylamine In N,N-dimethyl-formamide at 50℃; for 12h;
Stage #2: With water In N,N-dimethyl-formamide at 20℃; for 1h;
Stage #3: With sodium methylate In methanol at 20℃; for 1h;
71.2%
In N,N-dimethyl-formamide at 20℃; for 18h;55%
6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

N-(6-deoxy-6-β-cyclodextrinyl)guanidinium chloride

N-(6-deoxy-6-β-cyclodextrinyl)guanidinium chloride

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 24h;89%
With N-ethyl-N,N-diisopropylamine In water at 20℃; for 24h;87%
With N-ethyl-N,N-diisopropylamine In water at 20℃; for 48h;85%
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 72h;

29390-67-8Relevant articles and documents

Preparation, characterization and biological evaluation of β-cyclodextrin-biotin conjugate based podophyllotoxin complex

Zhao, Xiu,Qiu, Neng,Ma, Yingyu,Liu, Junda,An, Lianying,Zhang, Teng,Li, Ziqin,Han, Xu,Chen, Lijuan

, (2021)

Podophyllotoxin is a natural occurring aryltetralin lignin with pronounced cytotoxic activity. However, its clinical application for cancer treatment has been blocked due to its poor water solubility and selectivity. In this work, biotin as a tumor specific ligand was coupled with β-cyclodextrin and the resulting biotin modified β-cyclodextrin was used to complex with podophyllotoxin to improve its aqueous solubility and tumor selectivity. The solubility of β-cyclodextrin was greatly enhanced(>16 times) by conjugating with biotin. podophyllotoxin/ mono-6-biotin-amino-6-deoxy-β-cyclodextrin inclusion complex was prepared by freeze-drying method and the complex behavior between mono-6-biotin-amino-6-deoxy-β-cyclodextrin and podophyllotoxin was studied by water solubility, phase solubility, Job's plot, UV spectroscopy, Proton Nuclear Magnetic Resonance, Rotating-frame Overhauser Effect Spectroscopy, Powder X-ray diffraction and Scanning electron microscopy. The solubility of podophyllotoxin/ mono-6-biotin-amino-6-deoxy-β-cyclodextrin complex was greatly improved(9 times) compared with Podophyllotoxin. The stability constant of podophyllotoxin/ mono-6-biotin-amino-6-deoxy-β-cyclodextrin complex (Ks= 415.29 M?1) was 3.2 times that of podophyllotoxin/β-cyclodextrin complex. The possible inclusion mode of podophyllotoxin/mono-6-biotin-amino-6-deoxy-β-cyclodextrin complex was inferred from the Proton Nuclear Magnetic Resonance and Rotating-frame Overhauser Effect Spectroscopy. The cellular uptake study showed that the introduction of biotin increased the cellular uptake of rhodamine-B/mono-6-biotin-amino-6-deoxy-β-cyclodextrin complex. Moreover, cell cytotoxicity study showed that the antitumor activity of podophyllotoxin/ mono-6-biotin-amino-6-deoxy-β-cyclodextrin complex was more potent than podophyllotoxin/β-cyclodextrin complex and free podophyllotoxin. The superior water solubility and enhanced cytotoxicity suggested that the mono-6-biotin-amino-6-deoxy-β-cyclodextrin associated inclusion complex might be a potential and promising delivery system for hydrophobic chemotherapeutics such as podophyllotoxin.

Aminated β-cyclodextrin-grafted Fe3O4-loaded gambogic acid magnetic nanoparticles: Preparation, characterization, and biological evaluation

Fang, Wei,Dai, Ya Ji,Wang, Ting,Gao, Hai Tao,Huang, Peng,Yu, Juan,Huang, He Ping,Wang, Dian Lei,Zong, Wei Lu

, p. 27136 - 27146 (2019)

Based on aminated β-cyclodextrin (6-NH2-β-CD)-grafted Fe3O4 and gambogic acid (GA) clathrate complexes, a nanoparticle delivery system was developed with the aim to achieve low irritation, strong targeting, and high bioavailability of a gambogic acid magnetic nanopreparation. 6-NH2-β-CD grafted onto Fe3O4 MNPs was demonstrated by high-resolution transmission electron microscopy, Fourier transform infrared spectroscopy, X-ray diffraction, zeta potential, and magnetic measurements. The average particle size of the Fe3O4?NH2-β-CD MNPs was 147.4 ± 0.28 nm and the PDI was 0.072 ± 0.013. The encapsulation efficiency, drug loading, zeta potential, and magnetic saturation values of the Fe3O4?NH2-β-CD MNPs were 85.71 ± 3.47%, 4.63 ± 0.04%, -29.3 ± 0.42 mV, and 46.68 emu g-1, respectively. Compared with free GA, the in vitro release profile of GA from Fe3O4?NH2-β-CD MNPs was characterized by two phases: an initial fast release and a delayed-release phase. The Fe3O4?NH2-β-CD MNPs displayed continuously increased cytotoxicity against HL-60 and HepG2 cell lines in 24 h, whereas the carrier Fe3O4?NH2-β-CD MNPs showed almost no cytotoxicity, indicating that the release of GA from the nanoparticles had a sustained profile and Fe3O4?NH2-β-CD MNPs as a tumor tissue-targeted drug delivery system have great potential. Besides, blood vessel irritation tests suggested that the vascular irritation could be reduced by the use of Fe3O4?NH2-β-CD MNPs encapsulation for GA. The t1/2 and the AUC of the Fe3O4?NH2-β-CD?GA MNPs were found to be higher than those for the GA solution by approximately 2.71-fold and 2.42-fold in a pharmacokinetic study, respectively. The better biocompatibility and the combined properties of specific targeting and complexation ability with hydrophobic drugs make the Fe3O4?NH2-β-CD MNPs an exciting prospect for the targeted delivery of GA.

Synthesis, characterization, and in vitro evaluation of artesunate-β-cyclodextrin conjugates as novel anti-cancer prodrugs

Jiang, Rui-Jian,Zhao, Yu-Lin,Chen, Yun-Jian,Xiao, Dan,Wang, Fen,Han, Bin,Yang, Jian,Liao, Xia-Li,Yang, Li-Juan,Gao, Chuan-Zhu,Yang, Bo

, p. 19 - 25 (2014)

A novel series of artesunate-β-cyclodextrin (ATS-β-CD) conjugates, in which artesunate (ATS) was coupled covalently to one of the primary hydroxyl groups of β-cyclodextrin (β-CD) through amino bond formation, were synthesized and characterized by 1H NMR, HRMS, 2D NMR (ROESY), X-ray diffraction (XRD), and thermogravimetric analysis (TGA). The results showed that the aqueous solubility of ATS-β-CD conjugates was 26-45 times better than that of free ATS. The cytotoxicity of the ATS-β-CD conjugates was evaluated on human colon cancer cell lines HCT116, LOVO, SW480, and HT-29, and the results indicated that ATS-2NβCD exhibited a very high cytotoxicity against HCT116, LOVO, and HT-29 with IC50 values of 0.58, 1.62, and 5.18 μmol/L, respectively. In addition, the supposition of better cytotoxicity was further supported by the control experiment of fluorescent cyclodextrin.

pH-sensitive β-cyclodextrin derivatives for the controlled release of Podophyllotoxin

Gao, Chuanzhu,Li, Fanjie,Liao, Xiali,Yang, Bo,Yang, Jing,Yang, Lei,Yang, Waixiang,Zhao, Yulin

, (2021)

An effective tumor targeting drug delivery systems was designed and synthesized by conjugating pH-sensitive maleamide derivatives to Mono-(6-deoxy-6-amino)-β-CD. Their characteristics and inclusion behaviors with insoluble anticancer drug PPT were investigated in both solution and solid state by means of 1H NMR and 2D-ROESY, XRD, DSC and SEM, which reveal PPT is successfully encapsulated in the cavity of CD derivatives with different stability constants (Ks). Water solubility of PPT are significantly increased to 60.35 and 22.89 mg·mL?1 after formation of inclusion complexes with host-1 and host-2, compared with free PPT (0.12 mg·mL?1). Their acid-controlled release has been studied in vitro by 1H NMR and UV-Vis spectra, living cells incubated with host 1-2 were observed by Inverted fluorescence microscope to confirm pH-response releasing. Moreover, host-1/PPT and host-2/PPT maintain effective cell proliferation inhibition to human cancer, while their cytotoxicity to normal cell is significantly reduced. Our work shows inspiring potential in tumor-targeted delivery and acid-controlled release of PPT both in vitro.

Fuel-Driven and Enzyme-Regulated Redox-Responsive Supramolecular Hydrogels

Jain, Mehak,Ravoo, Bart Jan

, p. 21062 - 21068 (2021)

Chemical reaction networks (CRN) embedded in hydrogels can transform responsive materials into complex self-regulating materials that generate feedback to counter the effect of external stimuli. This study presents hydrogels containing the β-cyclodextrin (CD) and ferrocene (Fc) host–guest pair as supramolecular crosslinks where redox-responsive behavior is driven by the enzyme–fuel couples horse radish peroxidase (HRP)–H2O2 and glucose oxidase (GOx)–d-glucose. The hydrogel can be tuned from a responsive to a self-regulating supramolecular system by varying the concentration of added reduction fuel d-glucose. The onset of self-regulating behavior is due to formation of oxidation fuel in the hydrogel by a cofactor intermediate GOx[FADH2]. UV/Vis spectroscopy, rheology, and kinetic modeling were employed to understand the emergence of out-of-equilibrium behavior and reveal the programmable negative feedback response of the hydrogel, including the adaptation of its elastic modulus and its potential as a glucose sensor.

Fluorescent sensors of molecular recognition. Modified cyclodextrins capable of exhibiting guest-responsive twisted intramolecular charge transfer fluorescence

Hamasaki, Keita,Ikeda, Hiroshi,Nakamura, Asao,Ueno, Akihiko,Toda, Fujio,Suzuki, Iwao,Osa, Tetsuo

, p. 5035 - 5040 (1993)

α-, β-, and γ-cyclodextrin derivatives bearing a p-(dimethylamino)benzoyl (DMAB) moiety (DMAB-αCyD, DMAB-βCyD, and DMAB-γCyD, respectively) have been synthesized as fluorescent sensors of molecular recognition. These compounds show dual fluorescence emission arising from normal planar (NP) and twisted intramolecular charge transfer (TICT) exited states, and among them strong TICT emission was observed for DMAB-βCyD. The induced circular dichroism spectra of the derivatives suggest that only DMAB-βCyD among other derivatives binds the DMAB moiety into its own cavity, forming an intramolecular inclusion complex. This conformation was confirmed by the analysis of its 1H-NMR data and was related to its strong TICT emission. The intensity of the TICT emission of DMAB-βCyD decreased markedly with increasing the concentration of cyclic alchols, monoterpenes, or steroids. This observation was explained by the guest-induced location change of the DMAB moiety from inside to outside of the cavity. Since the TICT emission intensity depended on the size, shape, and polarity of the guest molecules, DMAB-βCyD was useful as a fluorescent chemosensor of molecular recognition.

Homodimerization and heteroassociation of 6-O-(2-sulfonato-6-naphthyl)-γ-cyclodextrin and 6-deoxy-(pyrene-1-carboxamido)-β-cyclodextrin

Park, Joon Woo,Song, Hee Eun,Lee, Soo Yeon

, p. 7071 - 7076 (2003)

6-O-(2-Sulfonato-6-naphthyl)-γ-cyclodextrin (1) and 6-deoxy-(pyrene-1-carboxamido)-β-cyclodextrin (2) were prepared. Homodimerizations of 1 and 2 and heteroassociation between 1 and 2 were investigated by 1H NMR, circular dichroism, and fluorescence spectroscopic methods. The compounds 1 and 2 form head-to-head dimers with dimerization constants of 140 ± 50 and 270 ± 70 M-1, respectively. We also determined the association constants of 1 with β-CD as 270 ± 20 M-1 and 2 with γ-CD as 100 ± 30 M-1 from fluorescence and circular dichroism titration data, respectively. The heteroassociation between 1 and 2 was manifested in increased circular dichroism ellipticities of 2, downfield shift of the H-2 proton of the pyrene group of 2, and upfield shift of the H-5 proton of the naphthyl group of 1 upon mixing 1 and 2. The analysis of circular dichroism titration data of 2 with 1 gave the association constant as 9300 ± 1600 M-1. The NMR and circular dichroism spectra suggested that the naphthyl group of 1 is deeply included into the β-CD cavity of 2, while the pyrene group of 2 is partially inserted in the γ-CD cavity of 1 in the complex. The energy-minimized structure from molecular modeling of the complex supports this. We believe that the facile heteroassociation of two cyclodextrin derivatives having different sizes of cavity and pendant group could be utilized as a useful strategy for assembling functionalized CDs for various applications.

Insight into the Excitation-Dependent Fluorescence of Carbon Dots

Divya, Sasi,Narayan, Satya,Ainavarapu, Sri Rama Koti,Khushalani, Deepa

, p. 984 - 990 (2019)

High quantum yield, photoluminescence tunability, and sensitivity to the environment are a few distinct trademarks that make carbon nanodots (CDs) interesting for fundamental research, with potential to replace the prevalent inorganic semiconductor quantum dots. Currently, application and fundamental understanding of CDs are constrained because it is difficult to make a quantitative comparison among different types of CDs simply because their photoluminescence properties are directly linked to their size distribution, the surface functionalization, the carbon core structures (graphitic or amorphous) and the number of defects. Herein, we report a facile one-step synthesis of mono-dispersed and highly fluorescent nanometre size CDs from a ‘family’ of glucose-based sugars. These CDs are stable in aqueous solutions with photoluminescence in the visible range. Our results show several common features in the family of CDs synthesized in that the fluorescence, in the visible region, is due to a weak absorption in the 300–400 nm from a heterogeneous population of fluorophores. Fluorescence quenching experiments suggest the existence of not only surface-exposed fluorophores but more importantly solvent inaccessible fluorophores present within the core of CDs. Interestingly, time-resolved fluorescence anisotropy experiments directly suggest that a fast exchange of excitation energy occurs that results in a homo-FRET based depolarization within 150 ps of excitation.

β-Cyclodextrin-Modified Magnetic Nanoparticles Immobilized on Sepharose Surface Provide an Effective Matrix for Protein Refolding

Ghaeidamini, Marziyeh,Kharat, Ali N.,Haertlé, Thomas,Ahmad, Faizan,Saboury, Ali A.

, p. 9907 - 9919 (2018)

In this article, we propose an impressive and facile strategy to improve protein refolding using solid phase artificial molecular chaperones consisting of the surface-functionalized magnetic nanoparticles. Specifically, monotosyl-β-cyclodextrin connected to the surface of 3-aminopropyltriethoxysilane (APES)-modified magnetic nanoparticles is immobilized on the sepharose surface to promote interaction with exposed hydrophobic surfaces of partially folded (intermediates) and unfolded states of proteins. Their efficiencies were investigated by circular dichroism spectroscopy and photoluminescence spectroscopy of the protein. Although the mechanism of this method is based on principles of hydrophobic chromatography, this system is not only purging the native protein from inactive inclusion bodies but also improving the protein refolding process. We chose β-cyclodextrin (β-CD) considering multiple reports in the literature about its efficiency in protein refolding and its biocompatibility. To increase the surface area/volume ratio of the sepharose surface by nanoparticles, more β-CD molecules are connected to the sepharose surface to make a better interaction with proteins. We suppose that proteins are isolated in the nanospace created by bound cyclodextrins on the resin surface so intermolecular interactions are reduced. The architecture of nanoparticles was characterized by Fourier transform infrared spectra, X-ray diffraction, scanning electron microscopy images, energy dispersive X-ray spectroscopy, nuclear magnetic resonance (1H NMR and 13C NMR), and dynamic light scattering.

Supramolecular self-assembled aggregates formed by pentacosa-10,12-diynyl amidomethyl-β-cyclodextrin

Cho, Eunae,Kim, Hwanhee,Yang, Jee Eun,Jun, Bong-Hyun,Paik, Seung R.,Jung, Seunho

, p. 37 - 42 (2014)

Mono[6-deoxy-6-(pentacosa-10,12-diynyl amidomethyl)]-β-cyclodextrin was successfully synthesized by reacting mono-6-amino-6-deoxy-β- cyclodextrin with N-hydroxysuccinimide ester of 10,12-pentacosadiynoic acid in DMF. The modified β-cyclodextrin self-assembled and aggregated to form a worm-like supramolecular structure, and the novel supramolecular aggregates were studied using 2D nuclear magnetic resonance spectroscopy, X-ray powder diffraction, thermogravimetry, and electron microscopy. Interestingly, the synthesized pentacosa-10,12-diynyl amidomethyl-β-cyclodextrin formed columnar type self-aggregates and it was clearly differentiated from cage-like structure of native β-cyclodextrin.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 29390-67-8